Frank Morich - 03 Mar 2025 Form 4 Insider Report for Perspective Therapeutics, Inc. (CATX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CATX	Stock option (right to buy)	Award	$0	+50,000		$0.000000	50,000	03 Mar 2025	Common Stock	50,000	$2.46	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option grant was approved by the Issuer's Board of Directors on February 12, 2025, with a grant date of March 3, 2025, and represents the Reporting Person's annual equity award for 2025.
F2	Option vests in full on March 3, 2026, subject to the Reporting Person's continued service on the vesting date.

Exhibit 24